Tweenvest Stocks

Stayble Therapeutics AB (publ) (DB: 4K4)

Health Care · Pharmaceuticals · SE

€—

— today · — 1Y

Stayble Therapeutics AB (publ) (DB: 4K4) operates in the Pharmaceuticals industry within the Health Care sector.

trading between 0.00 and 0.05.

Tweenvest scores Stayble Therapeutics AB (publ) across four factors: quality 45/100. Its strongest factor is quality.

4K4 price history

Not enough price history to draw a chart yet.

Key figures

Market cap
—
Revenue (TTM)
$-1.79K
P/E
—
EPS
—
Dividend yield
—
Beta (5Y)
—
52-week high
€0.05
52-week low
€0.00
Avg volume (3M)
—
Shares outstanding
—
Employees
2
Next earnings
—

About Stayble Therapeutics AB (publ)

Stayble Therapeutics AB (publ) is dedicated to pioneering an injectable therapy aimed at treating persistent lower back pain that stems from spinal disc degeneration. The company's key development is STA363, a pharmaceutical designed as a single, minimally invasive injection administered directly into the disc to combat chronic lumbar discomfort. This Swedish firm was established in 2015 and is headquartered in Gothenburg.

ISIN
SE0013513652
Founded
2015
Listed since
Mar 9, 2020
Exchange
Deutsche Boerse AG
Currency
EUR
CompanyMarket capPriceDay
Regnum Corp.OTCPK: RGMP$23.00$——
CanaQuest Medical Corp.OTCPK: CANQ.F$21.00$——
The Greenrose Holding Company Inc.OTCPK: GNRS.Q$18.00$——
Lowell Farms Inc.OTCPK: LOWL.F$18.00$0.00—
West Island Brands Inc.OTCPK: WIBF.F$17.00$0.00—
9 Meters Biopharma, Inc.OTCPK: NMTR.Q$14.00$——
Biostar Pharmaceuticals, Inc.OTCPK: BSPM$3.00$0.00—
BC Craft Supply Co. Ltd.OTCPK: CRFT.F$2.00$——

Browse every Pharmaceuticals company →

Figures last refreshed Oct 11, 2026.